Mesoblast Ltd ADR (MESO): Next-Year EPS Estimate 119.72%
As of 2026-06-04, Mesoblast Ltd ADR (MESO) has a next-year EPS growth estimate of 119.72%.
On 2026-05-31, analyst consensus for MESO's next-year EPS growth shifted from 120.21% to 119.72% — a negative change of 0.49 percentage points. The revised estimate has been sustained across 5 subsequent trading sessions. Current-year growth is projected at 59.69%.
Current Snapshot
- Sector
- Healthcare
- Industry
- Biotechnology
- EPS growth next year
- 119.72%
- EPS growth this year
- 59.69%
- EPS next quarter (est)
- $0.00
- Last price
- $14.93
EPS Revision History
| Date | EPS Next Y | EPS This Y | Next Q (est) | Price |
|---|---|---|---|---|
| 2026-06-04 | 119.72% | 59.69% | $0.00 | $14.93 |
| 2026-06-03 | 119.72% | 59.69% | $0.00 | $14.52 |
| 2026-06-02 | 119.72% | 59.69% | $0.00 | $14.52 |
| 2026-06-01 | 119.72% | 59.69% | $0.00 | $14.86 |
| 2026-05-31 | 119.72% | 59.69% | $0.00 | $15.40 |
| 2026-05-28 | 120.21% | 65.45% | $0.00 | $14.76 |
| 2026-05-27 | 120.21% | 65.45% | $0.00 | $14.66 |
| 2026-05-26 | 120.21% | 65.45% | $0.00 | $14.90 |
| 2026-05-25 | 120.21% | 65.45% | $0.00 | $15.20 |
| 2026-05-24 | 120.21% | 65.45% | $0.00 | $15.20 |
| 2026-05-21 | 120.21% | 65.45% | $0.00 | $14.98 |
| 2026-05-20 | 120.21% | 65.45% | $0.00 | $14.52 |
| 2026-05-19 | 120.21% | 65.45% | $0.00 | $14.55 |
| 2026-05-18 | 120.21% | 65.45% | $0.00 | $14.64 |
| 2026-05-17 | 120.21% | 65.45% | $0.00 | $14.99 |
| 2026-05-14 | 120.21% | 65.45% | $0.00 | $15.08 |
| 2026-05-13 | 120.21% | 65.45% | $0.00 | $14.72 |
| 2026-05-12 | 120.21% | 65.45% | $0.00 | $14.44 |
| 2026-05-11 | 120.21% | 65.45% | $0.00 | $14.51 |
| 2026-05-10 | 120.21% | 65.45% | $0.00 | $14.74 |
| 2026-05-07 | 120.21% | 65.45% | $0.00 | $14.80 |
| 2026-05-06 | 120.21% | 65.45% | $0.00 | $15.81 |
| 2026-05-05 | 120.21% | 65.45% | $0.00 | $15.79 |
| 2026-05-04 | 120.21% | 65.45% | $0.00 | $16.00 |
| 2026-05-03 | 120.21% | 65.45% | $0.00 | $15.74 |
| 2026-04-30 | 139.66% | 65.79% | $0.00 | $15.67 |
| 2026-04-29 | 139.66% | 65.79% | $0.00 | $15.55 |
| 2026-04-28 | 126.16% | 57.18% | $0.00 | $15.22 |
| 2026-04-27 | 126.16% | 57.18% | $0.00 | $15.33 |
| 2026-04-26 | 126.16% | 57.18% | $0.00 | $15.51 |
Recent News
Screen Performance
Aggregate stats across all 1761 tickers our top-EPS-revision screen has flagged over the past 64 days.
- Median return since detection
- +5.1%
- % of tickers in the green
- 62%
- Median return on winners
- +17.5%
- Large revisions captured
- 746
Past detection performance reflects the price change between when a ticker first entered our screen and the most recent observation. Not a forward-looking forecast.
Frequently Asked Questions
What is Mesoblast Ltd ADR's next-year EPS growth estimate?▾
As of 2026-06-04, Mesoblast Ltd ADR (MESO) has a next-year EPS growth estimate of 119.72%, based on analyst consensus.
When was the latest EPS estimate revision for MESO?▾
The most recent revision occurred on 2026-05-31, when analysts adjusted the next-year EPS growth estimate from 120.21% to 119.72%.
What sector and industry does Mesoblast Ltd ADR belong to?▾
Mesoblast Ltd ADR operates in the Healthcare sector, specifically the Biotechnology industry.
How often is this EPS estimate data updated?▾
EPS revision data is refreshed daily from analyst consensus estimates. MESO appears on this page because it was flagged by our daily top-EPS-revision-performer screen.
EPS revision data sourced from analyst consensus estimates, refreshed daily. Mesoblast Ltd ADR (MESO) appears here because it was detected by our daily top-EPS-revision-performer screen.
← All reports